(Hypertension. 1996;28:682-686.)
© 1996 American Heart Association, Inc.
Articles |
Mechanism of the Hypotensive Action of Anandamide in Anesthetized Rats
the Department of Pharmacology and Toxicology, Virginia Commonwealth University, Medical College of Virginia, Richmond (K.V., K.D.L., G.K.), and Department of Pharmacology, University of Virginia School of Medicine, Charlottesville (D.H., P.G.G.).
We studied the effects of the endogenous cannabinoid ligand anandamide on blood pressure, single unit activity of barosensitive neurons in the rostral ventrolateral medulla, and postganglionic splanchnic sympathetic nerve discharge in urethane-anesthetized rats. In rats with an intact baroreflex, an intravenous bolus of 4 mg/kg anandamide caused a triphasic blood pressure response: transient hypotension, followed by a brief pressor and more prolonged depressor phase. Anandamide evoked a "primary" increase in neuronal firing coincident with its pressor effect and a "secondary," baroreflex-mediated rise coincident with its depressor effect at both sites. Pretreatment of rats with phentolamine or trimethaphan did not inhibit either the pressor response or the primary increase in splanchnic nerve discharge elicited by anandamide. In barodenervated rats, electrical stimulation of the rostral ventrolateral medulla increased blood pressure and splanchnic nerve discharge. Anandamide treatment blunted the rise in blood pressure without affecting the increase in splanchnic nerve discharge. Anandamide did not affect the rise in blood pressure in response to an intravenous bolus dose of phenylephrine. The results indicate that (1) the brief pressor response to anandamide is not sympathetically mediated, and (2) the prolonged hypotensive response to anandamide is not initiated in the central nervous system, in ganglia, or at postsynaptic adrenergic receptors but is due to a presynaptic action that inhibits norepinephrine release from sympathetic nerve terminals in the heart and vasculature.
Key Words: cannabinoids • receptors, presynaptic • sympathetic nervous system • hypotension
This article has been cited by other articles:
 |
|
 |
|
  P. Pacher, P. Mukhopadhyay, R. Mohanraj, G. Godlewski, S. Batkai, and G. Kunos Modulation of the Endocannabinoid System in Cardiovascular Disease: Therapeutic Potential and Limitations Hypertension, October 1, 2008; 52(4): 601 - 607. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, M. Novotny, V. Quaiserova-Mocko, G. M. Swain, and D. H. Wang TRPV1-mediated protection against endotoxin-induced hypotension and mortality in rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1517 - R1523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Williams, S. A. Smith, D. E. O'Brien, J. H. Mitchell, and M. G. Garry The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor J. Physiol., February 1, 2008; 586(3): 835 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. O'Sullivan, M. D. Randall, and S. M. Gardiner The in Vitro and in Vivo Cardiovascular Effects of {Delta}9-Tetrahydrocannabinol in Rats Made Hypertensive by Chronic Inhibition of Nitric-Oxide Synthase J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 663 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, N. E. Kaminski, and D. H. Wang Endocannabinoid Regulates Blood Pressure via Activation of the Transient Receptor Potential Vanilloid Type 1 in Wistar Rats Fed a High-Salt Diet J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 763 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sade, K. Muraki, S. Ohya, N. Hatano, and Y. Imaizumi Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids Am J Physiol Cell Physiol, January 1, 2006; 290(1): C77 - C86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, N. E. Kaminski, and D. H. Wang VR1-Mediated Depressor Effects During High-Salt Intake: Role of Anandamide Hypertension, October 1, 2005; 46(4): 986 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pacher, S. Batkai, and G. Kunos Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice J. Physiol., July 15, 2004; 558(2): 647 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Seagard, C. Dean, S. Patel, D. J. Rademacher, F. A. Hopp, W. T. Schmeling, and C. J. Hillard Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H992 - H1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Rademacher, S. Patel, F. A. Hopp, C. Dean, C. J. Hillard, and J. L. Seagard Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1570 - H1576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Offertaler, F.-M. Mo, S. Batkai, J. Liu, M. Begg, R. K. Razdan, B. R. Martin, R. D. Bukoski, and G. Kunos Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor Mol. Pharmacol., March 1, 2003; 63(3): 699 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mukhopadhyay, B. M. Chapnick, and A. C. Howlett Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2046 - H2054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Garcia Jr., Z. Jarai, F. Mirshahi, G. Kunos, and A. J. Sanyal Systemic and portal hemodynamic effects of anandamide Am J Physiol Gastrointest Liver Physiol, January 1, 2001; 280(1): G14 - G20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Niederhoffer and B. Szabo Cannabinoids Cause Central Sympathoexcitation and Bradycardia in Rabbits J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 707 - 713. [Abstract] [Full Text]
|
|
|
|
|
|
C. J. Hillard Endocannabinoids and Vascular Function J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 27 - 32. [Abstract] [Full Text]
|
|
|
|
|
|
Z. Jarai, J. A. Wagner, S. K. Goparaju, L. Wang, R. K. Razdan, T. Sugiura, A. M. Zimmer, T. I. Bonner, A. Zimmer, and G. Kunos Cardiovascular Effects of 2-Arachidonoyl Glycerol in Anesthetized Mice Hypertension, February 1, 2000; 35(2): 679 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Jarai, J. A. Wagner, K. Varga, K. D. Lake, D. R. Compton, B. R. Martin, A. M. Zimmer, T. I. Bonner, N. E. Buckley, E. Mezey, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors PNAS, November 23, 1999; 96(24): 14136 - 14141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Gebremedhin, A. R. Lange, W. B. Campbell, C. J. Hillard, and D. R. Harder Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2085 - H2093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ishioka and R. D. Bukoski A Role for N-Arachidonylethanolamine (Anandamide) as the Mediator of Sensory Nerve-Dependent Ca2+-Induced Relaxation J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 245 - 250. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. G. Hohmann, K. Tsou, and J. M. Walker Cannabinoid Suppression of Noxious Heat-Evoked Activity in Wide Dynamic Range Neurons in the Lumbar Dorsal Horn of the Rat J Neurophysiol, February 1, 1999; 81(2): 575 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wagner, K. Varga, Z. Jarai, and G. Kunos Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors Hypertension, January 1, 1999; 33(1): 429 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Varga, J. A. Wagner, D. T. Bridgen, and G. Kunos Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension FASEB J, August 1, 1998; 12(11): 1035 - 1044. [Abstract] [Full Text]
|
|
|
|
|
|
K. D. Lake, D. R. Compton, K. Varga, B. R. Martin, and G. Kunos J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1030 - 1037. [Abstract] [Full Text]
|
|
|
|
|
|
K. D. Lake, B. R. Martin, G. Kunos, and K. Varga Cardiovascular Effects of Anandamide in Anesthetized and Conscious Normotensive and Hypertensive Rats Hypertension, May 1, 1997; 29(5): 1204 - 1210. [Abstract] [Full Text]
|
|
|
|
|
|
S. Mukhopadhyay, B. M. Chapnick, and A. C. Howlett Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2046 - H2054. [Abstract] [Full Text] [PDF]
|
|